Dolki Korea Co., Ltd.

Company Description

Company Introduction

The Korea Dolggy Incorporation has succeeded in adjusting the concentration of low-level hypochlorus acid that had been considered impossible for the medical purpose for the first time in the world. The low-level hypochlorus acid is used as an antiseptic solution for the human mucous membrane diseases and the skin for sterilizing over 99% of the bacteria, fungi, and virus without tolerance or side effects that the antispetic and antibiotics might arise.

Dolki Korea Co., Ltd. has registered 14 patent cases and proceeded with seven PCTs to 28 countries to jump to a global company.

We promise to contribute to the human health and better life by effectively and economically controlling the microorganisms.